IBM and Fujitsu Frontech North America have launched a new security offering that integrates palm vein biometric technology from Fujitsu with IBM’s enterprise single sign on offering.
The companies said that the new offering aims to help companies manage multiple passwords for access to business information by enabling employees to scan their palms to verify their identities. By integrating the palm vein technology with IBM’s single sign-on software, employees can securely access applications, files and websites with a single scan of their palm.
The offeirng combines Fujitsu PalmSecure Logondirector with IBM Tivoli Access Manager for Single Sign-On, providing organisations with an authentication service for protecting data while also complying with HIPAA, Sarbanes Oxley, PCI DDS and other industry and federal regulations, the companies said.
The palm vein identification utilises no trace technology that leaves virtually no biometric footprint behind and therefore it is difficult to spoof, especially when compared with cheaper fingerprinting devices, the company claims.
According to IBM, its Tivoli Access Manager for Enterprise Single Sign-On allows a user to log in once to gain access to various systems or applications to do their jobs without being prompted to log in again at each of them.
Jim Preasmyer, director of sales and business development for advanced technology group at Fujitsu Frontech of North America, said: “The combination of PalmSecure Logondirector and IBM Tivoli Access Manager for Enterprise Single Sign-On validates that strong biometric authentication is a critical component in addressing IT security and compliance requirements.
“We are proud to partner with IBM, one of the leading management and single sign-on providers, to expand PalmSecure Logondirector adoption. This partnership underscores Fujitsu’s commitment to partnering with world-class organisations to resolve security issues associated with lost, stolen or forgotten passwords.”
